Novadip Press Release
2025-04-29

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

No refractures were reported during…
read more
Novadip Press Release
2025-04-24

Novadip reports key nonclinical and interim clinical data for NVDX3, its off-the-shelf allogeneic product, in spine fusion

Novadip reports key nonclinical and…
read more
Minoryx Press Release
2025-03-04

Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral Adrenoleukodystrophy

Minoryx announces dosing of the…
read more
ONA Press Release
2025-02-19

ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors

Ona Therapeutics Strengthens Leadership Team…
read more
Novadip Press Release
2024-10-17

Novadip reports promising interim results from its first-in-human proof-of-concept trial with NVDX3, a new game changer in the bone field

At six months post-grafting surgery…
read more
Confo Therapeutics Press Release
2024-07-29

Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into Clinical Development

• Proceeds to support Phase…
read more
Press Release Tubulis
2024-06-21

Tubulis Doses First Patient in Phase I/IIa Trial Investigating ADC Candidate TUB-040 in Ovarian Cancer and Lung Adenocarcinoma

TUB-040 is a next-generation NaPi2b-targeting…
read more
Cardior Press Release
2024-04-09

Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease

Bagsværd, Denmark, and Hannover, Germany,…
read more
Press Release Tubulis
2024-03-14

Fund+ Portfolio Company Tubulis Closes Upsized EUR 128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline

Financing round co-led by EQT…
read more
Confo Therapeutics Press Release
2023-08-30

Confo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer Pharmaceuticals, as Independent Chairman

Ghent, Belgium – August 29,…
read more